PATENT CLAIM ANALYSIS

Application Number: 16225484
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I: wherein W, X, Y, Z, R 1 , R 2 , R 5 , and R 8  are as described herein.

Claim (Index 26):
A compound of any one of  claims 1 - 16  for use in the manufacture of a medicament for treating a disease associated with inhibiting one or more of BET-family bromodomains.

Metadata:
- Claim Count in Document: 115.0
- Percentile: 98.0
- Lexical Diversity: 1.37778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14546775', '15937271', '14546896', '16029166', '16016955']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8352283862573973
- 35 USC 102 Novelty (BERT): 0.6295144924281961
- Combined Prediction Score: 0.8146569968744771
- Mean Citation Score: 488.26624
- Max Citation Score: 655.55743
- Similarity Product: 448.3177122643059

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test